Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 4
1958 2
1959 2
1961 1
1962 8
1963 10
1964 10
1965 10
1966 10
1967 10
1968 11
1969 15
1970 14
1971 8
1972 7
1973 2
1974 5
1975 16
1976 7
1977 13
1978 9
1979 10
1980 14
1981 12
1982 12
1983 26
1984 18
1985 24
1986 30
1987 21
1988 23
1989 51
1990 30
1991 36
1992 29
1993 30
1994 20
1995 35
1996 26
1997 39
1998 29
1999 39
2000 32
2001 50
2002 44
2003 44
2004 53
2005 59
2006 43
2007 44
2008 49
2009 55
2010 56
2011 58
2012 76
2013 94
2014 91
2015 66
2016 41
2017 62
2018 65
2019 93
2020 111
2021 120
2022 87
2023 81
2024 106
2025 96
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,308 results

Results by year

Filters applied: . Clear all
Page 1
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions.
Nasr SH, Royal V, Best Rocha A, Büttner-Herold M, Roufosse C, Bridoux F, Ismail W, Bu L, Cornell LD, Dendooven A, Gupta RK, Hara S, Javaugue V, Kozakowski N, Kudose S, Méndez GP, Oliver K, Picken MM, Santoriello D, Sethi S, Shimizu A, Singh G, Stokes MB, Wang SX, Leung N, Markowitz GS, D'Agati VD. Nasr SH, et al. Among authors: hara s. Kidney Int. 2025 Aug;108(2):184-193. doi: 10.1016/j.kint.2025.04.007. Epub 2025 Apr 23. Kidney Int. 2025. PMID: 40280412
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial.
Shiraishi Y, Nomura S, Sugawara S, Horinouchi H, Yoneshima Y, Hayashi H, Azuma K, Hara S, Niho S, Morita R, Yamaguchi M, Yokoyama T, Yoh K, Kurata T, Okamoto H, Okamoto M, Kijima T, Kasahara K, Fujiwara Y, Murakami S, Kanda S, Akamatsu H, Takemoto S, Kaneda H, Kozuki T, Ando M, Sekino Y, Fukuda H, Ohe Y, Okamoto I. Shiraishi Y, et al. Among authors: hara s. Lancet Respir Med. 2024 Nov;12(11):877-887. doi: 10.1016/S2213-2600(24)00185-1. Epub 2024 Aug 16. Lancet Respir Med. 2024. PMID: 39159638 Clinical Trial.
Foreword.
Hara S. Hara S. Biol Pharm Bull. 2022;45(8):978. doi: 10.1248/bpb.b22-ctf4508. Biol Pharm Bull. 2022. PMID: 35908906 Free article. No abstract available.
Effect of Spinal Cord Burst Stimulation vs Placebo Stimulation on Disability in Patients With Chronic Radicular Pain After Lumbar Spine Surgery: A Randomized Clinical Trial.
Hara S, Andresen H, Solheim O, Carlsen SM, Sundstrøm T, Lønne G, Lønne VV, Taraldsen K, Tronvik EA, Øie LR, Gulati AM, Sagberg LM, Jakola AS, Solberg TK, Nygaard ØP, Salvesen ØO, Gulati S. Hara S, et al. JAMA. 2022 Oct 18;328(15):1506-1514. doi: 10.1001/jama.2022.18231. JAMA. 2022. PMID: 36255427 Free PMC article. Clinical Trial.
Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: A systematic review and meta-analysis.
Furukawa Y, Nagaoka D, Sato S, Toyomoto R, Takashina HN, Kobayashi K, Sakata M, Nakajima S, Ito M, Yamamoto R, Hara S, Sakakibara E, Perlis M, Kasai K. Furukawa Y, et al. Among authors: hara s. J Affect Disord. 2024 Dec 15;367:359-366. doi: 10.1016/j.jad.2024.09.017. Epub 2024 Sep 4. J Affect Disord. 2024. PMID: 39242039 Free article.
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.
Urabe F, Imai Y, Goto Y, Tashiro K, Hashimoto M, Yoshihara K, Yamamoto S, Hara S, Miyajima K, Fukuokaya W, Enei Y, Iwatani K, Kayano S, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Tsuzuki S, Murakami M, Hata K, Shimomura T, Yamada H, Miki J, Kimura T. Urabe F, et al. Among authors: hara s. Jpn J Clin Oncol. 2024 Nov 2;54(11):1208-1213. doi: 10.1093/jjco/hyae098. Jpn J Clin Oncol. 2024. PMID: 39037966
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World Setting.
Sato Y, Sumikawa H, Shibaki R, Morimoto T, Sakata Y, Oya Y, Tamiya M, Suzuki H, Matsumoto H, Yokoi T, Hashimoto K, Kobe H, Hino A, Inaba M, Tsukita Y, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Sakata S, Fujimoto D. Sato Y, et al. Among authors: hara s. Chest. 2022 Nov;162(5):1188-1198. doi: 10.1016/j.chest.2022.05.035. Epub 2022 Jun 1. Chest. 2022. PMID: 35661746
Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial.
Shibaki R, Fujimoto D, Miyauchi E, Tsukita Y, Nakachi I, Arai D, Sakata Y, Shingu N, Shimokawa T, Kijima T, Tamiya M, Kawana S, Hara S, Saito G, Sato Y, Yokoyama T, Sakata S, Taniguchi Y, Hata A, Matsumoto H, Yamaguchi T, Yamamoto N. Shibaki R, et al. Among authors: hara s. Lung Cancer. 2024 Oct;196:107958. doi: 10.1016/j.lungcan.2024.107958. Epub 2024 Sep 19. Lung Cancer. 2024. PMID: 39312871 Clinical Trial.
Apolipoprotein E-related glomerular disorders.
Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E. Saito T, et al. Among authors: hara s. Kidney Int. 2020 Feb;97(2):279-288. doi: 10.1016/j.kint.2019.10.031. Epub 2019 Nov 22. Kidney Int. 2020. PMID: 31874799 Free article. Review.
2,308 results